Standing Ovation Raises $34.2M for Precision Fermentation Proteins

French innovator Standing Ovation has successfully closed a $34.2 million (€30 million) Series B funding round, propelling its mission to revolutionize dairy protein production through precision fermentation. The substantial capital infusion is earmarked for accelerating the commercialization of its proprietary casein, a key dairy protein, with an initial focus on the North American market before expanding into Europe and Asia by late 2027.

The financing was co-led by the Ecotechnologies 2 fund, managed by Bpifrance on behalf of the French government as part of the France 2030 initiative, and Crédit Mutuel Innovation. This strategic backing underscores the growing confidence in sustainable food technologies. Existing investors, including Astanor, Bel Group, Seventure Partners, GoodStartUp, and Big Idea Ventures, participated, joined by new strategic investors Danone Ventures, Angelor, Newtree, and Noshaq. An additional $5.7 million (€5 million) in non-dilutive financing from Bpifrance and a banking syndicate further bolsters the company's growth trajectory.

Standing Ovation's core innovation lies in its patented process that transforms dairy co-products, specifically whey permeates, into high-value casein. This approach not only addresses the escalating global demand for protein—projected to require an additional 250 million metric tons by 2050—but also offers a more sustainable and domestically controlled alternative to traditional dairy farming. The company highlights that its method achieves a significant 74% reduction in greenhouse gas emissions and uses up to three times less water compared to conventional casein production, according to ISO-certified life cycle assessments.

The strategic involvement of major agri-food players like Danone and Bel Group as shareholders is a significant endorsement. Their participation signals a broader industry shift towards embracing novel protein sources that enhance food security and reduce environmental impact. Standing Ovation's model aims to create a symbiotic relationship with the dairy sector, turning underutilized by-products into profitable new revenue streams for farmers while providing the food industry with a reliable, high-performance protein ingredient.

CEO Yvan Chardonnens emphasized the company's vision: “Our ambition is to pioneer a new, circular, and sustainable approach to protein production to meet rapidly growing global demand. By combining technological innovation with the dairy industry’s expertise, we are bridging the gap between the agri-food industry and deep tech.” The company, co-founded by Managing Director Romain Chayot, has secured its technology through eight patent families, creating substantial barriers to entry in this rapidly evolving market.

This Series B funding is critical for Standing Ovation as it navigates the complex path to market. The company is strategically partnering with established fermentation manufacturers rather than building its own facilities, allowing for a faster scale-up. The global alternative protein market is experiencing robust growth, driven by consumer demand for healthier, more sustainable, and ethically produced food options. Precision fermentation, in particular, is gaining traction as a method to produce complex ingredients like dairy proteins without the environmental and ethical concerns associated with traditional animal agriculture.